EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Magnetic Resonance Imaging–Transrectal Ultrasound Fusion‐Targeted Biopsy Improves the Diagnostic Efficacy of Overall and Clinically Significant Prostate Cancer

Yusuke Fukiage iD, Minekatsu Taga, Mahiro Inamura, Kimika Kaeriyama, Nobuki Tanaka, Wonseok Seo, Tadashi Kakitsuba, Sahoko Shimada, Nodoka Okubo, Takafumi Kabuto, Manami Tsutsumiuchi, Yoshinaga Okumura und 4 weitere

International Journal of Urology · 2026

DOI: 10.1111/iju.70334 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift International Journal of Urology, 2026. Verfasst von Yusuke Fukiage und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Faculty of Medical Sciences, University of Fukui, Eiheiji, Japan. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Image-Guided Biopsy, Prostate, Ultrasonography, Interventional. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

As the diagnostic efficacy and safety of magnetic resonance imaging (MRI)–transrectal ultrasound (TRUS) fusion‐targeted transrectal biopsy for prostate cancer (PCa) detection have already been demonstrated when compared with those of conventional systematic biopsy, we aimed to further evaluate them.

Methods

In this retrospective study, we included patients who underwent MRI–TRUS fusion‐targeted transrectal biopsy combined with systematic biopsy between 2022 and 2024. The detection rates for overall and clinically significant PCa and adverse event (≥ grade 3) rates were assessed. The results were compared with those of conventional systematic biopsies using propensity score matching.

Results

In 223 patients who underwent MRI–TRUS fusion biopsy combined with systematic biopsy (initial biopsy, 161; repeat biopsy, 62), the median prostate‐specific antigen level was 8.0 ng/mL; the median prostate volume was 35 mL. The overall, clinically significant, and insignificant PCa detection rates were 67%, 60%, and 8%, respectively. After propensity score matching, detection rates were significantly higher in the MRI–TRUS fusion group than in the control group for overall PCa (66% vs. 49%, p = 0.005) and clinically significant PCa (58% vs. 41%, p = 0.005), but were not significantly different for clinically insignificant PCa (8% vs. 8%, p = 1.000). The adverse event rate (≥ grade 3) was not significantly different between the groups (3% vs. 3%, p = 1.000).

Conclusions

Compared with conventional biopsy, MRI–TRUS fusion‐targeted transrectal biopsy combined with systematic biopsy could effectively detect clinically significant PCa without increasing detection of clinically insignificant PCa and adverse event rates.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsImage-Guided BiopsyProstateUltrasonography, InterventionalMagnetic Resonance ImagingMagnetic Resonance Imaging, InterventionalHumansMaleRetrospective StudiesAgedMiddle AgedProstate-Specific AntigenRectumPropensity Score

Stichwörter der Autor:innen

image‐guided biopsyinterventional ultrasonographymagnetic resonance imagingneedle biopsyprostatic neoplasms

Substanzen

Prostate-Specific Antigen

Autor:innen und Institutionen

  • Department of Urology, Faculty of Medical Sciences, University of Fukui, Eiheiji, Japan.
  • Department of Pathology, Faculty of Medical Sciences, University of Fukui, Eiheiji, Japan.

ORCID-Profile: Yusuke Fukiage, Naoki Terada

Zitieren

APA

Fukiage, Y., Taga, M., Inamura, M., Kaeriyama, K., Tanaka, N., Seo, W., Kakitsuba, T., Shimada, S., Okubo, N., Kabuto, T., Tsutsumiuchi, M., Okumura, Y., Muramoto, A., Seki, M., Inamura, S., & Terada, N. (2026). Magnetic Resonance Imaging–Transrectal Ultrasound Fusion‐Targeted Biopsy Improves the Diagnostic Efficacy of Overall and Clinically Significant Prostate Cancer. International Journal of Urology. https://doi.org/10.1111/iju.70334

Vancouver

Fukiage Y, Taga M, Inamura M, Kaeriyama K, Tanaka N, Seo W, et al. Magnetic Resonance Imaging–Transrectal Ultrasound Fusion‐Targeted Biopsy Improves the Diagnostic Efficacy of Overall and Clinically Significant Prostate Cancer. International Journal of Urology. 2026. doi:10.1111/iju.70334

BibTeX
@article{Fukiage2026,
  author = {Fukiage, Yusuke and Taga, Minekatsu and Inamura, Mahiro and Kaeriyama, Kimika and Tanaka, Nobuki and Seo, Wonseok and Kakitsuba, Tadashi and Shimada, Sahoko and Okubo, Nodoka and Kabuto, Takafumi and Tsutsumiuchi, Manami and Okumura, Yoshinaga and Muramoto, Akifumi and Seki, Masaya and Inamura, So and Terada, Naoki},
  title = {Magnetic Resonance Imaging–Transrectal Ultrasound Fusion‐Targeted Biopsy Improves the Diagnostic Efficacy of Overall and Clinically Significant Prostate Cancer},
  journal = {International Journal of Urology},
  year = {2026},
  doi = {10.1111/iju.70334}
}
Kostenlos starten →